Order Article Reprints

Scheipner L, Zurl H, Altziebler JV, Pichler GP, Schöpfer-Schwab S, Jasarevic S, Gaisl M, Pohl KC, Pemberger K, Andlar S, et al. Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer. Cancers. 2023; 15(24):5770. https://doi.org/10.3390/cancers15245770

Scheipner, Lukas, Hanna Zurl, Julia V. Altziebler, Georg P. Pichler, Stephanie Schöpfer-Schwab, Samra Jasarevic, Michael Gaisl, Klara C. Pohl, Karl Pemberger, Stefan Andlar, and et al. 2023. "Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer" Cancers 15, no. 24: 5770. https://doi.org/10.3390/cancers15245770

Scheipner, L., Zurl, H., Altziebler, J. V., Pichler, G. P., Schöpfer-Schwab, S., Jasarevic, S., Gaisl, M., Pohl, K. C., Pemberger, K., Andlar, S., Hutterer, G. C., Bele, U., Leitsmann, C., Leitsmann, M., Augustin, H., Zigeuner, R., Ahyai, S., & Mischinger, J. (2023). Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer. Cancers, 15(24), 5770. https://doi.org/10.3390/cancers15245770